Lichen International Limited
LICN
$3.16
-$0.14-4.24%
NASDAQ
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 9.05M | 9.05M | 11.92M | 11.92M | 7.96M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 9.05M | 9.05M | 11.92M | 11.92M | 7.96M |
| Cost of Revenue | 3.57M | 3.57M | 4.67M | 4.67M | 3.05M |
| Gross Profit | 5.48M | 5.48M | 7.25M | 7.25M | 4.91M |
| SG&A Expenses | 4.63M | 4.63M | 2.54M | 2.54M | 3.49M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.20M | 8.20M | 7.21M | 7.21M | 6.54M |
| Operating Income | 851.00K | 851.00K | 4.70M | 4.70M | 1.43M |
| Income Before Tax | 883.50K | 883.50K | 4.72M | 4.72M | 1.08M |
| Income Tax Expenses | 500.00K | 500.00K | 1.23M | 1.23M | 398.00K |
| Earnings from Continuing Operations | 383.50K | 383.50K | 3.49M | 3.49M | 678.50K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 383.50K | 383.50K | 3.49M | 3.49M | 678.50K |
| EBIT | 851.00K | 851.00K | 4.70M | 4.70M | 1.43M |
| EBITDA | 1.05M | 1.05M | 4.82M | 4.82M | 1.68M |
| EPS Basic | 2.58 | 2.58 | 26.34 | 26.34 | 5.29 |
| Normalized Basic EPS | 3.71 | 3.71 | 22.25 | 22.25 | 5.25 |
| EPS Diluted | 2.58 | 2.58 | 26.34 | 26.34 | 5.29 |
| Normalized Diluted EPS | 3.71 | 3.71 | 22.25 | 22.25 | 5.25 |
| Average Basic Shares Outstanding | 148.70K | 148.70K | 132.50K | 132.50K | 128.20K |
| Average Diluted Shares Outstanding | 148.70K | 148.70K | 132.50K | 132.50K | 128.20K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |